Search for “
”
Searching map area
Y
Y
N
N
Y
Y
N
N
Home
Map
Random
Rate Things
Explore
Everything
Film
TV
Music
Books
Games
People
Characters
Places
Food
Life
Ideas
Organizations
News
Memes
Other
Join YYNN
Sign in
Multiple myeloma
Subject of
Popular
Trending
New
Popular
Popular
Trending
New
Best
Worst
Controversial
Uncontroversial
Best
Worst
Controversial
Uncontroversial
Elotuzumab plus lenalidomide and dexamethasone in relapsed/refractory multiple myeloma: Extended 4-year follow-up and analysis of relative progression-free survival from the randomized ELOQUENT-2 trial
?
TBD
scientific article published on 11 September 2018